Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Microsoft Corp. €466.75 €478.95
Alphabet Inc. A €169.24 €189.60
Amazon.com Inc. €184.74 €222.13
Security Price Target price
Tesla Inc €268.80 €296.66
Hershey Co. €163.54 €138.11
Texas Capital Bancshares €69.50 €69.59

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

This new day by Dom Ruinart
Total
€99,991
Cash
€41,119
Performance (%)
0.011%

Pros and Cons of these stocks (New Predictions)

Syndax Pharmaceuticals Inc

WKN: A2AFL6 / Name: Syndax / Stock / Pharmaceuticals / Small Cap /

Pros
2
Could be very worthwhile Investment >20% year
Cons
Replimune Group Inc

WKN: A2JQN1 / Symbol: REPL / Name: Replimune Group / Stock / Small Cap /

Pros
4
Could be worthwhile Investment >10% per year
Cons
3
Few uniques
1
Dependend from some customers or products
1
Growths slower than the competition
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Zoetis Inc. A €142.16 8.250%
Zebra Technologies A €318.00 7.650%
Leidos Holdings Inc. €147.00 5.530%
DuPont de Nemours Inc. €64.46 5.170%
Discovery Communications C €22.42 5.110%
Security Price Change(%) (%)
Gartner Inc. €234.00 -19.640%
Vertex Pharmaceuticals Inc. €354.25 -13.140%
Henry Schein Inc. €55.00 -9.210%
Transdigm Group €1,276.0 -8.330%
Eaton Corp. €317.20 -4.620%

Courses

sharewise Introduction:
sharewise Introduction
This is a course about the functionalities of sharewise. You will learn about the basics and how to best use the platform.
Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.

Predictions

buy
Syndax Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€10.50
14:01
€25.00
31.12.27
0.00%
14:37

Could be very worthwhile Investment >20% year
buy
Evonik Industries AG

Start price
Target price
Perf. (%)
€16.47
12:00
-
05.08.26
0.43%
14:43

buy
Sfc Energy AG

Start price
Target price
Perf. (%)
€15.86
12:00
-
05.08.26
0.50%
14:45

buy
Db X-trackers Ii Eonia Ucits Etf

Start price
Target price
Perf. (%)
€146.89
01:25
-
05.08.26
0.01%
14:47

Top News

News

Is ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) a Strong ETF Right Now?
Is ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) a Strong ETF Right Now?

Making its debut on 02/03/2015, smart beta exchange traded fund ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) provides

Should iShares Morningstar Mid-Cap ETF (IMCB) Be on Your Investing Radar?
Should iShares Morningstar Mid-Cap ETF (IMCB) Be on Your Investing Radar?

Looking for broad exposure to the Mid Cap Blend segment of the US equity market? You should consider the iShares Morningstar Mid-Cap ETF (IMCB), a passively managed exchange traded fund launched on

Is Invesco S&P 500 Equal Weight Consumer Discretionary ETF (RSPD) a Strong ETF Right Now?
Is Invesco S&P 500 Equal Weight Consumer Discretionary ETF (RSPD) a Strong ETF Right Now?

Making its debut on 11/01/2006, smart beta exchange traded fund Invesco S&P 500 Equal Weight Consumer Discretionary ETF (RSPD) provides

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

The First Trust Health Care AlphaDEX ETF (FXH) was launched on May 8, 2007, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the

Should Vanguard Russell 1000 ETF (VONE) Be on Your Investing Radar?
Should Vanguard Russell 1000 ETF (VONE) Be on Your Investing Radar?

The Vanguard Russell 1000 ETF (VONE) was launched on September 22, 2010, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US

Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?
Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?

Launched on November 8, 2005, the SPDR S&P Dividend ETF (SDY) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Value segment of the US equity market.

Should You Invest in the Vanguard Consumer Staples ETF (VDC)?
Should You Invest in the Vanguard Consumer Staples ETF (VDC)?

Designed to provide broad exposure to the Consumer Staples - Broad segment of the equity market, the Vanguard Consumer Staples ETF (VDC) is a passively managed exchange traded fund launched on

Should You Invest in the First Trust NASDAQ-100-Technology Sector ETF (QTEC)?
Should You Invest in the First Trust NASDAQ-100-Technology Sector ETF (QTEC)?

Looking for broad exposure to the Technology - Broad segment of the equity market? You should consider the First Trust NASDAQ-100-Technology Sector ETF (QTEC), a passively managed exchange traded

Should JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) Be on Your Investing Radar?
Should JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) Be on Your Investing Radar?

Looking for broad exposure to the Small Cap Value segment of the US equity market? You should consider the JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC), a passively managed exchange traded

Contest

Compete in Catch the Monkey ...

... and win a prize!

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren